Zinc-α2-glycoprotein is involved in regulation of body weight through inhibition of lipogenic enzymes in adipose tissue

International Journal of Obesity

Volumn 33, Issue 9, 2009, Pages 1023-1030

  Gong, F Y ^a   Zhang, S J ^b   Deng, J Y ^a   Zhu, H J ^a   Pan, H ^a   Li, N S ^a   Shi, Y F ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b People Hospital of Shanxi Province   (China)

Author keywords

Adipose tissue; Fatty acid synthase; Hormone sensitive lipase; Zinc 2 glycoprotein

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; DIACYLGLYCEROL ACYLTRANSFERASE 1; FATTY ACID SYNTHASE; GLYCOPROTEIN; HORMONE SENSITIVE LIPASE; LIPOSOME; UNCLASSIFIED DRUG; ZINC ALPHA2 GLYCOPROTEIN; SEMINAL PLASMA PROTEIN; ZN ALPHA 2 GLYCOPROTEIN; ZN-ALPHA-2-GLYCOPROTEIN;

ADIPOSE TISSUE; ADULT; AGE DISTRIBUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; EPIDIDYMIS FAT; FAT BODY; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HIP; HUMAN; LIPID DIET; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN FUNCTION; SEX DIFFERENCE; WAIST CIRCUMFERENCE; WEIGHT CONTROL; ADIPOCYTE; ANIMAL; BLOOD; ENZYMOLOGY; GENETICS; LIPOLYSIS; METABOLISM; MOUSE MUTANT; PHYSIOLOGY;

MUS;

ADIPOCYTES; ADIPOSE TISSUE; ADULT; ANIMALS; BODY WEIGHT; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LIPOLYSIS; MALE; MICE; MICE, OBESE; OBESITY; SEMINAL PLASMA PROTEINS;

EID: 70349104688     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2009.141     Document Type: Article

References (29)

1. Ahima RS. Adipose tissue as an endocrine organ. Obesity (Silver Spring) 2006; 14 (Suppl 5): 242S-249S.
2. Burgi W, Schmid K. Preparation and properties of Zn-alpha 2-glycoprotein of normal human plasma. J Biol Chem 1961; 236: 1066-1074.
3. Poortmans JR, Schmid K. The level of Zn-alpha 2-glycoprotein in normal human body fluids and kidney extract. J Lab Clin Med 1968; 71: 807-811.
4. Bondar OP, Barnidge DR, Klee EW, Davis BJ, Klee GG. LC-MS/MS quantification of Zn-alpha-2 glycoprotein: a potential serum biomarker for prostate cancer. Clin Chem 2007; 53: 673-678.
5. Stejskal D, Karpisek M, Reutova H, Stejskal P, Kotolova H, Kollar P. Determination of serum zinc-alpha-2-glycoprotein in patients with metabolic syndrome by a new ELISA. Clin Biochem 2008; 41: 313-316.
6. Hirai K, Hussey HJ, Barber MD, Price SA, Tisdale MJ. Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients. Cancer Res 1998; 58: 2359-2365.
7. Hale LP, Price DT, Sanchez LM, Demark-Wahnefried W, Madden JF. Zinc alpha-2-glycoprotein is expressed by malignant prostatic epithelium and may serve as a potential serum marker for prostate cancer. Clin Cancer Res 2001; 7: 846-853.
8. Russell ST, Zimmerman TP, Domin BA, Tisdale MJ. Induction of lipolysis in vitro and loss of body fat in vivo by zinc-alpha-2-glycoprotein. Biochim Biophys Acta 2004; 1636: 59-68.
9. Bing C, Bao Y, Jenkins J, Sanders P, Manieri M, Cinti S et al. Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia. Proc Natl Acad Sci USA 2004; 101: 2500-2505.
10. Bao Y, Bing C, Hunter L, Jenkins JR, Wabitsch M, Trayhurn P. Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed and secreted by human (SGBS) adipocytes. FEBS Lett 2005; 579: 41-47.
11. Berndt J, Kovacs P, Ruschke K, Kloting N, Fasshauer M, Schon MR et al. Fatty acid synthase gene expression in human adipose tissue: association with obesity and type 2 diabetes. Diabetologia 2007; 50: 1472-1480.
12. Diraison F, Dusserre E, Vidal H, Sothier M, Beylot M. Increased hepatic lipogenesis but decreased expression of lipogenic gene in adipose tissue in human obesity. Am J Physiol Endocrinol Metab 2002; 282: E46-E51.
13. Boizard M, Le Liepvre X, Lemarchand P, Foufelle F, Ferre P, Dugail I. Obesity-related overexpression of fatty-acid synthase gene in adipose tissue involves sterol regulatory element-binding protein transcription factors. J Biol Chem 1998; 273: 29164-29171.
14. Rolland V, Liepvre XL, Jump DB, Lavau M, Dugail I. A GC-rich region containing Sp1 and Sp1-like binding sites is a crucial regulatory motif for fatty acid synthase gene promoter activity in adipocytes. Implication In the overactivity of FAS promoter in obese Zucker rats. J Biol Chem 1996; 271: 21297-21302.
15. Chen HC, Stone SJ, Zhou P, Buhman KK, Farese Jr RV. Dissociation of obesity and impaired glucose disposal in mice overexpressing acyl coenzyme a:Diacylglycerol acyltransferase 1 in white adipose tissue. Diabetes 2002; 51: 3189-3195.
16. Sztalryd C, Komaromy MC, Kraemer FB. Overexpression of hormone-sensitive lipase prevents triglyceride accumulation in adipocytes. J Clin Invest 1995; 95: 2652-2661.
17. Jocken JW, Langin D, Smit E, Saris WH, Valle C, Hul GB et al. Adipose triglyceride lipase and hormone-sensitive lipase protein expression is decreased in the obese insulin-resistant state. J Clin Endocrinol Metab 2007; 92: 2292-2299.
18. Carlsson E, Johansson LE, Strom K, Hoffstedt J, Groop L, Holm C et al. The hormone-sensitive lipase C-60G promoter polymorphism is associated with increased waist circumference in normal-weight subjects. Int J Obes (Lond) 2006; 30: 1442-1448.
19. Gong FY, Shi YF, Deng JY. The regulatory mechanism by which interleukin-6 stimulates GH-gene expression in rat GH3 cells. J Endocrinol 2006; 190: 397-406.
20. Gong FY, Deng JY, Shi YF. IFN-gamma increases the hGH gene promoter activity in rat GH3 cells. Horm Res 2003; 60: 14-20.
21. Gong FY, Deng JY, Shi YF. Stimulatory effect of interleukin-1beta on growth hormone gene expression and growth hormone release from rat GH3 cells. Neuroendocrinology 2005; 81: 217-228.
22. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408.
23. Todorov PT, McDevitt TM, Meyer DJ, Ueyama H, Ohkubo I, Tisdale MJ. Purification and characterization of a tumor lipid-mobilizing factor. Cancer Res 1998; 58: 2353-2358.
24. Kamoshida S, Watanabe K, Suzuki M, Mizutani Y, Sakamoto K, Sugimoto Y et al. Expression of cancer cachexia-related factors in human cancer xenografts: An immunohistochemical analysis. Biomed Res 2006; 27: 275-281.
25. Groundwater P, Beck SA, Barton C, Adamson C, Ferrier IN, Tisdale MJ. Alteration of serum and urinary lipolytic activity with weight loss in cachectic cancer patients. Br J Cancer 1990; 62 : 816-821.
26. Marrades MP, Martinez JA, Moreno-Aliaga MJ. ZAG, a lipid mobilizing adipokine, is downregulated in human obesity. J Physiol Biochem 2008; 64: 61-66.
27. Dahlman I, Kaaman M, Olsson T, Tan GD, Bickerton AS, Wahlen K et al. A unique role of monocyte chemoattractant protein 1 among chemokines in adipose tissue of obese subjects. J Clin Endocrinol Metab 2005; 90: 5834-5840.
28. Rolli V, Radosavljevic M, Astier V, Macquin C, Castan-Laurell I, Visentin V et al. Lipolysis is altered in MHC class I zinc-alpha(2)-glycoprotein deficient mice. FEBS Lett 2007; 581: 394-400.
29. Russell ST, Tisdale MJ. Effect of a tumour-derived lipid-mobilising factor on glucose and lipid metabolism in vivo. Br J Cancer 2002; 87 : 580-584.